Enzymes for Molecular Biology: Enzymes for Molecular Biology
T7 R&DNA™ Polymerases
T7 R&DNA™ Polymerases - Mutant T7 RNA Polymerases for synthesis of RNA, DNA, or transcripts of mixed dNMP/rNMP or modified 2"-NMP/rNMP composition
BioSearch Tech (Lucigen/Epicentre)
| Catalogue No. | Description | Pack Size | Price | Qty |
|
|---|---|---|---|---|---|
| D7P9205K | T7 R&DNA™ Polymerase | 50U/µl 5,000U | £439.00 | Quantity | Add to Order |
Related products
T7 R&DNA™ Polymerases
T7 R&DNA™ Polymerases - Mutant T7 RNA Polymerases for synthesis of RNA, DNA, or transcripts of mixed dNMP/rNMP or modified 2"-NMP/rNMP composition
BioSearch Tech (Lucigen/Epicentre)
T7 R&DNA™ Polymerase* is a recombinant mutant form of T7 RNA polymerase (Y639F mutant), in which Tyr-639 has been replaced by Phe.1,2 This mutation enables T7 R&DNA Polymerase to incorporate 2´-deoxyribonucleoside triphosphates (dNTPs) into full-length transcripts much more efficiently than the corresponding wild-type enzyme,1 while retaining the same catalytic activity for incorporation of canonical NTPs, and the same high promoter specificity as wild-type T7 RNA Polymerase. The ability of this mutant enzyme to incorporate certain 2´-modified-dNTPs (including but not limited to dNTPs having a 2´-fluorine or 2´-amino group) enables efficient in vitro synthesis of transcripts composed of mixed rNMP/2´-dNMP or rNMP/2´- modified-dNMP from any DNA template that is downstream of the T7 RNA polymerase promoter. Such modified transcripts are useful for many applications.
Note: Complete substitution of one 2´-dNTP (or one 2´-modified dNTP) for a canonical rNTP in a T7 R&DNA Polymerase reaction results in a slight decrease in yield. Additional substitutions of 2´-dNTPs (or 2´-modified-dNTPs) for canonical rNTPs will further reduce yield of the transcript produced. Substitution with all four 2´-dNTPs (or 2´-modified dNTPs) will result in extremely low yields of transcript and is NOT RECOMMENDED.
If you cannot find the answer to your problem below then please contact us or telephone 01954 210 200
T7 R&DNA™ Polymerases
T7 R&DNA™ Polymerases - Mutant T7 RNA Polymerases for synthesis of RNA, DNA, or transcripts of mixed dNMP/rNMP or modified 2"-NMP/rNMP composition
BioSearch Tech (Lucigen/Epicentre)
Protocol for: T7 R&DNA™ Polymerases
T7 & SP6 R&DNA™ Polymerase Protocol
(catalogue number D7P9201K / D7P9205K / D6P9301K / D6P9305K)
Please note: all protocols off site are the responsibility of the products supplier
If you cannot find the answer to your problem below then please contact us or telephone 01954 210 200
T7 R&DNA™ Polymerases
T7 R&DNA™ Polymerases - Mutant T7 RNA Polymerases for synthesis of RNA, DNA, or transcripts of mixed dNMP/rNMP or modified 2"-NMP/rNMP composition
BioSearch Tech (Lucigen/Epicentre)
References
- Sousa, R and Padilla, R. (1995) EMBO J. 14 (18), 4609.
- U.S. Patent Nos. 5,849,546 and 6,107,037.
If you cannot find the answer to your problem below then please contact us or telephone 01954 210 200
T7 R&DNA™ Polymerases
T7 R&DNA™ Polymerases - Mutant T7 RNA Polymerases for synthesis of RNA, DNA, or transcripts of mixed dNMP/rNMP or modified 2"-NMP/rNMP composition
BioSearch Tech (Lucigen/Epicentre)
*T7 R&DNA Polymerase is covered by patents issued and pending.
These products are accompanied by a limited non-exclusive license for the purchaser to use the purchased product(s) solely for life science research. No license for any other field of use or immunity under any patent covering any other use is either granted or implied by the sale of the product. Contact the Intellectual Property Manager at Epicentre® Biotechnologies for information on licenses for uses other than life science research.
 | Get your Epicentre® Forum - hot off the press!Click here for direct link to Forum listings |
If you cannot find the answer to your problem below then please contact us or telephone 01954 210 200
T7 R&DNA™ Polymerases
T7 R&DNA™ Polymerases - Mutant T7 RNA Polymerases for synthesis of RNA, DNA, or transcripts of mixed dNMP/rNMP or modified 2"-NMP/rNMP composition
BioSearch Tech (Lucigen/Epicentre)
Applications
- Synthesis of "RNA" transcripts of mixed rNMP/2´-dNMP or rNMP/2´-modified-NMP composition.
- Synthesis of modified "RNA" transcripts that are resistant to RNase A-type RNases
If you cannot find the answer to your problem below then please contact us or telephone 01954 210 200
AthensResearch&Technology公司位于美国乔治亚州雅典市，从1986年以来一直致力于纯化高纯度，高活性的人类蛋白质和开发这些蛋白的多克隆抗血清。我们的常规产品包括丝氨酸蛋白酶、蛋白酶抑制剂、中性粒细胞酶、载脂蛋白、脂蛋白，血小板蛋白、转铁蛋白、免疫球蛋白等。二十年多年来，世界各地的研究人员都在使用我们公司的产品。在炎症、冠状动脉疾病、自身免疫性疾病、癌症、老年痴呆症等等研究的主要科学出版物中都能看到引用我们公司的产品。我们提供优质，可靠的产品和出色的客户服务。我们期待着您的业务。如果需要定制研究服务，AthensResearch&Technology公司能够根据您的项目要求提供无与伦比的试剂。
公司主要产品：一、凝血因子相关系列产品：包括多款从人血浆、血小板中分离纯化的凝血因子相关蛋白。二、酶及抑制剂系列产品：包括多款从人血浆、红细胞分离纯化的a-抗糜蛋白酶、a1/2抗胰蛋白酶、抗凝血酶、C1酯酶抑制因子、Calpain-1等酶及其抑制剂产品。三、免疫球蛋白系列产品：包括多款从人血浆、骨髓瘤、初乳以及狗和小鼠血浆中分离纯化的免疫球蛋白产品。四、脂蛋白及载脂蛋白系列产品：包括包括多款从人血浆中分离纯化的载脂蛋白及脂蛋白（高密度、中等密度、低密度、极低密度脂蛋白）产品。五、低内毒素蛋白系列产品：包括多款适宜于细胞培养的低内毒素脂蛋白、免疫球蛋白及转铁蛋白产品。六、乳蛋白系列产品：包括从人乳中分离纯化的乳白蛋白、乳铁传递蛋白及分泌型免疫球蛋白A。七、中性粒细胞源蛋白系列产品：包括多款纯化分离自人中性粒细胞的Azurocidin 、CathepsinG及Lactoferrin等蛋白产品。八、血小板相关系列产品：包括纯化分离自人血小板的血小板因子4及凝血酶致敏蛋白。九、转铁蛋白及脱铁转铁蛋白（APOTRANSFERRINS）系列产品：包括多款纯化分离自人、大小鼠、狗及食蟹猴血浆中的转铁蛋白/脱铁转铁蛋白，可应用于细胞或组织培养。十、抗体系列产品：包括多款兔、大鼠、羊源的多克隆抗体产品。
ebiomall.com
